0001209191-19-048075.txt : 20190904 0001209191-19-048075.hdr.sgml : 20190904 20190904131846 ACCESSION NUMBER: 0001209191-19-048075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190901 FILED AS OF DATE: 20190904 DATE AS OF CHANGE: 20190904 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Knickerbocker Aron Marc CENTRAL INDEX KEY: 0001578766 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 191073884 MAIL ADDRESS: STREET 1: C/O FIVE PRIME THERAPEUTICS, INC. STREET 2: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FIVE PRIME THERAPEUTICS INC DATE OF NAME CHANGE: 20020613 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-09-01 0 0001175505 FIVE PRIME THERAPEUTICS, INC. FPRX 0001578766 Knickerbocker Aron Marc 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President & CEO Common Stock 2019-09-01 4 F 0 3306 5.43 D 42057 D Common Stock 200299 I By the Aron M. Knickerbocker Revocable Trust Since the date of the reporting person's last ownership report, he transferred 2,848 shares of common stock to the Aron M. Knickerbocker Revocable Trust. Includes 1,623 shares acquired on May 15, 2019 pursuant to Five Prime Therapeutics, Inc.'s 2013 Employee Stock Purchase Plan. /s/ Francis Sarena, Attorney-in-fact 2019-09-04